Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jan 7, 2008; 14(1): 58-63
Published online Jan 7, 2008. doi: 10.3748/wjg.14.58
Published online Jan 7, 2008. doi: 10.3748/wjg.14.58
Disease-free survival | Overall survival | |||
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Child-Pugh classification | ||||
B vs A | 2.05 (1.25-3.35) | 0.004 | 2.46 (1.38-4.41) | 0.002 |
Tumor size | ||||
≥ 5 vs < 5 cm | 1.26 (0.83-1.92) | 0.282 | 1.30 (0.75-2.25) | 0.350 |
Macroscopic findings1 | ||||
Confluent type vs | 1.10 (0.75-1.61) | 0.626 | 1.58 (0.92-2.72) | 0.098 |
Simple nodular type | ||||
Number of tumor | ||||
Multiple vs Solitary | 1.23 (0.82-1.85) | 0.306 | 1.73 (1.03-2.91) | 0.037 |
Vascular involvement | ||||
Yes vs No | 1.24 (0.68-2.27) | 0.481 | 1.76 (0.93-3.31) | 0.080 |
Alpha-feto protein level | ||||
≥ 400 vs < 400 ng/mL | 1.41 (0.93-2.11) | 0.103 | 1.36 (0.81-2.28) | 0.250 |
Treatment modality | ||||
Ablation vs Hepatectomy | 0.75 (0.46-1.22) | 0.239 | 0.64 (0.39-1.34) | 0.334 |
- Citation: Nanashima A, Masuda J, Miuma S, Sumida Y, Nonaka T, Tanaka K, Hidaka S, Sawai T, Nagayasu T. Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score. World J Gastroenterol 2008; 14(1): 58-63
- URL: https://www.wjgnet.com/1007-9327/full/v14/i1/58.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.58